 |
alliReport |
 |
Your INDEPENDENT source of news about the new diet drug alli (low-dose Xenical) |
|||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||
| alli News from May 2005 -- News About Low-Dose Xenical | |
New Rimonabant Clinical Trial to Begin Enrolling Participants in Next Few Weeks
|
|
The 3 week alli exhibit (at 20 Union Square in NYC) opens to the press on 5/21 & 22, then to the public. Obesity experts, researchers, MDs, RDs and more will be available at the press events. http://www.myalli.com/ http://www.visualwebcaster.com/event.asp?id=39331 |
|
Other Diet Resources
We subscribe to the HONcode principles of the HON Foundation. This is an independent news site reporting on alli, a half-strength version of the diet drug Xenical (orlistat), which GlaxoSmithKlein hopes to market under the trademarked name alli. Nothing on this site is intended to infringe on that trademark. Nothing on this site is intended as medical advice. The information provided is for informational purposes only. Always consult a doctor or medical professional with questions regarding a medical condition.
Last Updated: 05/17/2007 Copyright 2004-2006 Medical Week News, Inc. All Rights Reserved
